Metallothionein & Human Tumor Resistance to Chemotherapy

Ernstoff, Marc S.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 3R01CA052166-01S1
• Application #: 3196943
• Study Section: Special Emphasis Panel (SRC (55))
• Project Start: 1990-05-01
• Project End: 1993-04-30
• Budget Start: 1990-08-22
• Budget End: 1991-04-30
• Support Year: 1
• Fiscal Year: 1990

Institution

• Name: University of Pittsburgh
• Type: Schools of Medicine
• DUNS #: 053785812
• City: Pittsburgh
• State: PA
• Country: United States
• Zip Code: 15213

Publications

Bahnson, R R; Becich, M; Ernstoff, M S et al. (1994) Absence of immunohistochemical metallothionein staining in bladder tumor specimens predicts response to neoadjuvant cisplatin, methotrexate and vinblastine chemotherapy. J Urol 152:2272-5

Kuo, S M; Kondo, Y; DeFilippo, J M et al. (1994) Subcellular localization of metallothionein IIA in human bladder tumor cells using a novel epitope-specific antiserum. Toxicol Appl Pharmacol 125:104-10

Bahnson, R R; Banner, B F; Ernstoff, M S et al. (1991) Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladder. J Urol 146:1518-20